1,152 reports of this reaction
3.2% of all KETOPROFEN reports
#1 most reported adverse reaction
HEADACHE is the #1 most commonly reported adverse reaction for KETOPROFEN, manufactured by Allegis Pharmaceuticals, Inc.. There are 1,152 FDA adverse event reports linking KETOPROFEN to HEADACHE. This represents approximately 3.2% of all 36,564 adverse event reports for this drug.
Patients taking KETOPROFEN who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among KETOPROFEN users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for KETOPROFEN:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 1,152 FDA reports for KETOPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.2% of all adverse event reports for KETOPROFEN, making it one of the most commonly reported side effect.
If you experience headache while taking KETOPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.